Bruker Corp

NASDAQ: BRKR
$55.89
+$2.52 (+4.7%)
Real Time Data Delayed 15 Min.

BRKR Stock Chart and Intraday Price

BRKR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 40 MANNING RD, BILLERICA, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 12,225.84M USD
Shares Outstanding 138,411,000
Bruker Corp is a global leader in developing and manufacturing advanced scientific instruments and solutions for a wide range of fields, including life sciences, diagnostics, and material analysis. With a strong focus on innovation, Bruker offers products like mass spectrometry systems, diagnostic kits, and nanotechnology tools. Their portfolio also includes cutting-edge research instruments for studying biological samples and materials at the molecular and atomic levels. Headquartered in Billerica, Massachusetts, Bruker is dedicated to supporting the scientific community with its diverse and technologically advanced offerings.

BRKR Articles

Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Wednesday’s top analyst upgrades and downgrades included Alliance Data, AvalonBay, Boston Properties, Bruker, Camden Properties and CBRE.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and Whirlpool.
The top analyst upgrades, downgrades and initiations seen on Thursday include Advanced Micro Devices, Caterpillar, NRG Energy, Nvidia, Procter & Gamble, Square, Red Hat, Transocean, Viacom and...
The top analyst upgrades, downgrades and other research calls from Friday include Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter and YogaWorks.
The top analyst upgrades, downgrades and other research calls from Thursday include Agilent Technologies, AT&T, Halcon Resources, HP, International Paper, Seagate technology and Snap.
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Biogen, Discovery Communications, Mosaic, Plains All American, Phillips 66 and Rubicon Project.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Dick's Sporting Goods, Randgold Resources, Royal Dutch Shell, Sysco and Tesla Motors.
Tuesday’s top analyst upgrades, downgrades and initiations include AT&T, Capital One, Cisco, Novartis, Sprint and Starbucks.
The top analyst calls for Thursday include Celgene, DigitalGlobe, Micron Technology, Paychex and Bed Bath & Beyond.
The major money management firms that run exchange traded funds have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels.
ThinkstockThe second-quarter earnings parade may be winding down as we hit August, but the number of companies meeting or exceeding expectations for the period continues to grow. The equity research...
There is a rather interesting IPO filing this morning from Bruker Energy & Supercon Technologies, Inc. Bruker Corporation (NASDAQ: BRKR) is the controlling shareholder and is going to be offering...
You know the market is still strong when secondary floodgates open up and are so well received that so many deals are seeing increased offerings.  Some of the deals we have seen this morning alone...